Building Permit Issued for 105 West First St. in South Boston
A building permit has been issued for early-stage construction to include utilities and foundation work for the 105 West First St. project in South Boston. The upcoming 7-story building will feature 250,000 square feet of R&D office space, ground floor retail, and a 35 car parking garage. Tishman Speyer purchased the project in July for $80M.
Permit Issued to Abandon Gas Service to Exchange South End Site in Prep for Demo
A permit has been pulled to abandon the gas service to 540 Albany Street in prep for demo. The demo will make way for the much-anticipated Exchange South End project which was approved by the BDPA over a year ago in August 2018. The four-building 1.6 million square foot project will offer a mix of office, lab, and retail space plus a new 1-acre public park. The first buildings in this new life science and technology campus are expected to be ready in Q1 2022.
Window and Facade Install Underway for The Beat
Windows are going in, and new sections of the brick facade are taking shape at The Beat in Dorchester. The redevelopment of the former Boston Globe headquarters will feature 695,000-square-feet of creative office, lab, and retail space. Amenities on-site will include a fitness center, roof deck, mini-basketball court, and a golf simulator. The project will also include a 100-seat restaurant and craft microbrewery.
As part of the renovation, Eversource is working with the development team at Nordblom to support the installation of energy-efficient infrastructure. High-efficiency rooftop air conditioning units will be used to condition and ventilate the building, and an LED lighting scheme will provide superior lighting quality while consuming minimal energy. The Beat will also include one of Eversource’s largest EV projects, featuring more than 40 spaces equipped with ports for charging electric vehicles. Construction is expected to wrap up this coming spring.
Renovation Work Ongoing at Exchange 200 in Malden
Construction is ongoing for the renovation of 200 Exchange St. in Malden into a modern innovation hub. Floor-to-ceiling glass will be added along the facade for additional natural lighting, and amenities will be constructed including a fitness center, networking spaces, and bike storage. Exchange 200 will feature 200,000 square feet of flexible commercial space intended for office and technology tenants, as well as over 16,000 square feet of ground-floor restaurant and retail space. Given its’ existing power and network redundancies, Exchange 200 will also include 60,000 square feet of energy-efficient data center space, including 25,000 square feet of critical operation space.
Akamai Moves into New Headquarters at 145 Broadway in Kendall Square
On November 1, Akamai Technologies held a ribbon-cutting celebration marking the grand opening of their new global headquarters at 145 Broadway in Kendall Square. The new headquarters consolidates six of the internet technology company’s local offices, allowing 2,000 employees in the area to work together under one roof. The new lobby and office space designed by Sasaki is housed within a base building by architect Pickard Chilton and architect of record Stantec. Responding to Akamai’s most pressing need to unite teams across a new 480,000 square foot office, Sasaki’s design prioritizes connection within the company, articulated best by the project’s vision statement: “To connect the world, we must first connect to each other.”
The colorful "Akamile" is a mile-long walking path created by Sasaki, the interior architect behind the office design. The connective pathway links all 19 floors of the new Akamai office, creating a band of social and collaborative space that connects teams across the 480,000 SF. The gradient runs between Akamai's brand colors of blue and orange, doubling as a fully integrated branding and wayfinding feature that sets this office apart as a beacon within Kendall Square.
Inspiring productive collaboration across the building’s 19-floor interior posed a challenge, but the Sasaki design team saw opportunity for innovative design. Diverse destinations—including specialty coffee bar, ping pong arena, and an inviting gaming lair, among others—encourage movement across the entire building, and a walkable physical path between the top and bottom floors of the building guides employees through common spaces on each floor. The path, which spans approximately one mile, is cleverly dubbed the “Akamile.”
Diverse destinations along a single walking path get people to move between all 19 floors, ensuring the Akamai workforce is staying connected to one another and given the mix of social, focused, and collaborative spaces they need to do their best work.
Photos: Sasaki, Interior Architect. ©Anton Grassl
Permit Pulled to Begin Foundation Work For LaGrange Street Tower
A permit has been issued to begin foundation work on the upcoming 21-story tower at 47-55 LaGrange Street. The project will feature up to 176 luxury residential units, a mix of studios through 2 bedrooms. The building will also include parking for 20 cars and 176 bikes.
CO Issued for 2 Brookline Place
A Certificate of Occupancy has been issued for the new Children's Hospital building at Two Brookline Place. The 182,500 square foot building features medical offices along with ambulatory care space over ground-floor retail.
Interior Finishing Nearly Complete for First Units at NEMA Boston
Interior finishing is wrapping up for the first units at NEMA Boston in the Seaport. The 414 unit apartment project will offer studios through three bedrooms currently ranging in price from around $2450 up through $8770 per month. NEMA will also feature around 2,500 square feet of retail, innovation, and lobby space on the ground floor along with parking for 144 cars.
31 Story Tower Under Review for 290 Tremont St.
The 31-story, 426,500 square foot mixed-use tower proposed at 286-290 Tremont Street in Chinatown is officially under review. Plans call for a 100% income-restricted residential tower with up to 171 affordable units a mix of rentals and condos, a hotel with up to 200 rooms, up to 340 off-street vehicle parking spaces, 2,500 square feet of retail/cafe space, and approximately 8,000 square feet of community space. Approximately 110 units at 290 Tremont are a direct result of the IDP requirements in the Winthrop Center project.
The development team, of Millennium Partners, in partnership with Corcoran Jennison, Asian Community Development Corporation, and Tufts Shared Services, Inc. hopes to commence construction in the second quarter of 2021, with initial occupancy by the second quarter of 2023.
Window Install Wrapping Up for South Bay Center Hotel
Windows install is nearly complete for the new Hilton hotel located in Dorchester's South Bay Center. The new 90,000 square foot hotel will feature 130 rooms along with 77 surface parking spaces. Construction on the hotel is set to be complete in 2020.
Three New Leases Signed at Cambridge Discovery Park
The Bulfinch Companies has announced it has signed three new leases with Arbor Biotechnologies, Kintai Therapeutics and Simcere Innovation, Inc. in Building 400‐500 at Cambridge Discovery Park (CDP), Bulfinch’s life sciences development in Cambridge, Massachusetts.
Currently under construction, Building 400‐500 is Bulfinch’s newest addition to CDP adding 283,000 SF of Class A lab and office space to the park with delivery of Q1 2020. These three new leases bring CDP Building 400‐500 to 88% leased with only 32,215 SF remaining available on the top sixth floor. Peter Bekarian, Managing Director at Jones Lang LaSalle, and leasing team served as the broker on behalf of Bulfinch. Evan Gallagher, Senior Vice President at Colliers International, and leasing team represented Arbor Biotechnologies, Mark Winters, Executive Managing Director, Newmark Knight Frank, and leasing team represented Kintai Therapeutics and Joseph Pearce, Director, Newmark Knight Frank, represented Simcere Innovation, Inc.
CDP’s Building 400‐500 is a state‐of‐the‐art, LEED Gold registered building, designed by Stantec, and located in a federally designated Economic Opportunity Zone. The six‐story building was topped off in April 2019 and is set to deliver in Q1 2020, with John Moriarty & Associates serving as General Contractor. The building is designed with a connector on the third through sixth floors over the private Discovery Way Drive with two distinct lobbies. The property includes unobstructed views of the Boston Skyline, including the Prudential Center, Hancock Tower and the new Four Seasons and close proximity to Alewife T Station. In June, Bulfinch announced that FogPharma and its affiliate company, LifeMine Therapeutics, both current tenants in CDP’s Building 100, will be relocating to occupy 114,490 SF in Building 400‐500, and will have signage rights with an exclusive lobby.
Arbor Biotechnologies will occupy 36,171 SF of space on the fifth floor in Building 400‐500. Arbor is an early‐stage company pushing the boundaries of biodiscovery by unlocking nature’s genetic diversity to create transformative products in human health and sustainability. Arbor’s proprietary platform integrates a computational search engine with high‐throughput experimental capabilities to enable both rapid protein characterization and product generation. Arbor was recently selected for MIT’s STEX25, a startup exchange featuring cutting‐edge industry‐ready startups that are poised for significant growth. This new, state‐of‐the‐art space in Building 500 will help support the company’s growth.
Kintai Therapeutics has leased a total of 72,296 SF on the third and fourth floors of Building 400‐500. Kintai was founded in 2016 by Flagship Labs, the innovation foundry of Flagship Pioneering. The company’s Precision Enteric MedicineTM (PEMTM) discovery and therapeutic platform is based on a deep understanding of the interconnected biology of the microbiome, gut immune system, and enteric nervous system. Kintai has pioneered a new frontier in gut science, resulting in a unique understanding of a wealth of new genes, metabolites, and signaling molecules, leveraging these insights to rapidly translate into a highly actionable pipeline. Kintai has a portfolio of more than ten programs focused on multiple therapeutic areas, including oncology, neurology, and immunology. Kintai is moving to CDP to meet its space requirements following continued momentum and growth.
“Kintai is developing pioneering therapeutics based on our unique understanding of the body’s enteric signaling network,” said Paul Peter Tak, M.D., Ph.D., president and chief executive officer of Kintai. “The company has been successful in utilizing a multidisciplinary approach to analyze and generate large integrated datasets and start multiple disease programs. We are pleased to have found the high‐class facilities required to accommodate the growth of the company and support the work we are doing to advance new treatments for patients in need.”
Simcere Innovation, Inc will occupy 26,349 SF on the second floor of Building 400‐500. Simcere Innovation is focusing on the research and development of life‐changing therapies to our patients using cutting‐edge technology, such as cell and gene therapies. The company is providing a very innovative model – “internal entrepreneurship” – to combine the research and development with open innovation and partnerships in an effective and creative way. Simcere Innovation is a company of Simcere Pharmaceutic Group, which is a China’s leading R&D‐driven pharmaceutical company and has been nationally ranked in China for a number of years. Simcere Innovation, which will serve as the company’s first US location and national headquarters, has collaborated with top companies, including Amgen and Bristol‐Myers Squibb, etc.
“Open innovation is Simcere’s core strategy. In 2013, Simcere established the BioSciKin innovation model and participated in multiple venture capital funds globally,” said Shawn Xu, Ph.D., Founder of Simcere Innovation Inc. “Cambridge is a global hub of life science and continues to be one of the most innovative cities on the planet. Simcere Innovation is aiming to leverage CDP’s global innovation resources to help accelerate our journey in making better medicine available to patients sooner.”
Situated in Alewife’s life science cluster, CDP has emerged as a desirable alternative to East Cambridge’s low vacancy constraints, offering ample space for innovators in Boston’s life science hub. This lab and office campus in Cambridge includes 400,000 square feet in three buildings, two parking garages with space for over 1,000 vehicles, including electric car charging stations, and a 150 room AC Marriott Hotel with conference center, restaurant and bar. Future amenities at Building 400‐500 will include an additional park café and a full‐service yoga and fitness center. Building 400‐500 will mark the completion of CDP’s construction and development.
Measuring 27 acres, CDP is one of the largest campuses in Cambridge, offering a unique natural environment surrounding Alewife Brook Reservation with a variety of walking trails and green space. While set in a natural location, CDP is easily accessible by foot or a short five‐minute shuttle ride from the Alewife MBTA Red Line Station, directly off Route 2 and nine minutes from Route 128. Amenities at CDP include outdoor seating and dining areas, multiple bike racks, bike storage, and bike-sharing and ATM banking.
“We are extremely pleased to announce that Arbor, Kintai and Simcere Innovation have chosen to select CDP’s newest Building 400‐500, bringing the total occupancy at the property to 88%,” said Mike Wilcox, SVP, Director of Leasing at Bulfinch. “Multiple leases signed prior to the building’s completion demonstrates the desire for additional lab, office and R+D space outside of Kendall Square that still maintains convenient access to the MBTA’s Red Line and ‘brain train’.”
Arbor, Kintai and Simcere Innovation will join other notable tenants currently leasing at CDP including Forrester Research, FogPharma, LifeMine Therapeutics, Genocea Biosciences, Inc. and The Smithsonian Astrophysical Observatory.
Harrison Street is a financial partner in the project, which has also worked closely with Bulfinch on several life science projects in the Greater Boston area. Citizens Commercial Real Estate Finance team is leading the construction loan for CDP Building 400‐500 as the lead arranger and administrative agent.
After Extensive Demo, The Beat Beginning to Show Signs of It's New Look
As construction continues on the revamp of The Beat, leasing efforts are also ramping up with new signage on the project (as we are sure anyone driving on 93S has noticed). Hints of the finished product are also beginning to show with some windows in and new steelwork in place over what will be the main entrance to the nearly 700,000 square foot project. Tenants and the public will be welcomed to the building via the new multi-story atrium which will create a central gathering area and feature a food hall and collaborative meeting spaces. The atrium will also allow natural light to circulate throughout the building.